290 related articles for article (PubMed ID: 16322213)
1. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
[TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å
Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203
[TBL] [Abstract][Full Text] [Related]
4. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
Staff S; Isola J; Tanner M
Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
[TBL] [Abstract][Full Text] [Related]
5. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
Rice JC; Massey-Brown KS; Futscher BW
Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
[TBL] [Abstract][Full Text] [Related]
7. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
10. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
[TBL] [Abstract][Full Text] [Related]
13. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
16. MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.
Chen Y; Zhou J; Xu Y; Li Z; Wen X; Yao L; Xie Y; Deng D
Cancer Sci; 2009 Sep; 100(9):1663-7. PubMed ID: 19522853
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
19. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
[TBL] [Abstract][Full Text] [Related]
20. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]